Without detection of deletion 17p or translocation 4;14;
Showing 1 - 25 of >10,000
People Who Have Genetic Changes and Features of Autism: Simons
Recruiting
- 16P11.2 Deletion Syndrome
- +184 more
-
New York, New York
- +1 more
Jan 6, 2023
Chronic Lymphocytic Leukemia, 17p Deletion, Cancer of the Blood and Bone Marrow Trial in Worldwide (ABT-199 (Main Cohort),
Completed
- Chronic Lymphocytic Leukemia
- +2 more
- ABT-199 (Main Cohort)
- ABT-199 (Safety Expansion Cohort)
-
Tucson, Arizona
- +47 more
Nov 19, 2021
Chronic Lymphocytic Leukemia Trial in Worldwide (Venetoclax)
Completed
- Chronic Lymphocytic Leukemia
-
Louisville, Kentucky
- +66 more
Nov 9, 2022
Brodalumab in Plaque Psoriasis to Understand Impact on Quality
Recruiting
- Psoriasis
- Brodalumab
- Matched cohort
-
Calgary, Alberta, Canada
- +33 more
Oct 8, 2022
Healthcare Resources in Chronic Lymphocytic Leukemia Initiating
Completed
- Chronic Lymphocytic Leukemia
-
Calgary, Alberta, Canada
- +12 more
Jul 7, 2022
DLBCL, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6
Recruiting
- Diffuse Large B-Cell Lymphoma
- +2 more
- Prednisone
- +6 more
-
Tampa, Florida
- +1 more
Jan 12, 2022
Chronic Lymphocytic Leukemia Trial in Germany (Obinutuzumab, Venetoclax, Acalabrutinib)
Recruiting
- Chronic Lymphocytic Leukemia
- Obinutuzumab
- +2 more
-
Bad Saarow, Germany
- +29 more
May 4, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Acalabrutinib (Arm A)
- Acalabrutinib (Arm B)
-
Bethesda, MarylandResearch Site
Jan 3, 2023
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Newly Diagnosed Multiple Myeloma Trial in Austria, Germany (Elotuzumab, Carfilzomib, Lenalidomide)
Active, not recruiting
- Newly Diagnosed Multiple Myeloma
- Elotuzumab
- +4 more
-
Krems, Lower Austria, Austria
- +55 more
Jan 4, 2022
Multiple Myeloma, Deletion 17P Syndrome Trial in Italy (Daratumumab, Pomalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Deletion 17P Syndrome
- Daratumumab
- +2 more
-
Ancona, Italy
- +14 more
Mar 24, 2022
Mesenteric Bacterial Translocation in Evolved Crohn's Disease
Recruiting
- Crohn Disease
-
Terrassa, Barcelona, SpainHospital Universitari MútuaTerrassa
May 26, 2023
Plaque Psoriasis Trial in Canada, United States (Roflumilast Cream 0.3%, Roflumilast Cream 0.15%, Vehicle Cream)
Completed
- Plaque Psoriasis
- Roflumilast Cream 0.3%
- +2 more
-
Beverly Hills, California
- +29 more
Aug 31, 2022
Alzheimer, Alzheimer 1, Alzheimer 2 Trial in United States (Sensory Stimulation System (GS120) - Active, Sensory Stimulation
Recruiting
- Alzheimer Disease
- +34 more
- Sensory Stimulation System (GS120) - Active
- Sensory Stimulation System (GS120) - Sham
-
Washington, District of Columbia
- +24 more
Jan 27, 2023
COPD (COPD) Trial in Worldwide (BGF MDI HFO 320/14.4/9.6 µg, BGF MDI HFA 320/14.4/9.6 µg)
Recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- BGF MDI HFO 320/14.4/9.6 μg
- BGF MDI HFA 320/14.4/9.6 μg
-
Phoenix, Arizona
- +96 more
Jan 23, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Leukemia
- Nemtabrutinib
- +7 more
- (no location specified)
Nov 30, 2022
Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney
Recruiting
- Rare Disorders
- +309 more
-
Sioux Falls, South Dakota
- +1 more
Jun 20, 2022
Photoaging Trial (In a double-blinded fashion, 250 mg CANNAXR cream, Topical VEHICLE cream)
Not yet recruiting
- Photoaging
- In a double-blinded fashion, 250 mg CANNAXR cream
- Topical VEHICLE cream
- (no location specified)
Aug 23, 2022
Leukemia, Leukemia, Lymphocytyc, CLL (Chronic Lymphocytic Leukemia) Trial run by the NHLBI (PCI 32765)
Active, not recruiting
- Leukemia
- +3 more
- PCI 32765
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 2, 2021
Infectious and Inflammatory Complications in Acute Bowel
Recruiting
- Intestinal Obstruction
- +4 more
- LBP
- +2 more
-
Karaganda, KazakhstanNJSC Karaganda Medical University
Feb 3, 2022
Healthy Trial in Philadelphia (Blood draw)
Active, not recruiting
- Healthy
- Blood draw
-
Philadelphia, PennsylvaniaThe Clinical Translational Research Center (CTRC) at the Hospita
Aug 16, 2022
Angelman Syndrome Trial (60 mg QD Alogabat, 40 mg QD Alogabat, 7 mg QD Alogabat)
Not yet recruiting
- Angelman Syndrome
- 60 mg QD Alogabat
- +4 more
- (no location specified)
Feb 1, 2023